287 related articles for article (PubMed ID: 37407214)
1. A Cross-Sectional Study of the Physical and Mental Well-Being of Long COVID Patients in Aruba.
Duwel V; de Kort JML; Becker CM; Kock SM; Tromp GG; Busari JO
Clin Med Res; 2023 Jun; 21(2):69-78. PubMed ID: 37407214
[No Abstract] [Full Text] [Related]
2. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
[TBL] [Abstract][Full Text] [Related]
3. Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
Fernández-de-Las-Peñas C; Rodríguez-Jiménez J; Cancela-Cilleruelo I; Guerrero-Peral A; Martín-Guerrero JD; García-Azorín D; Cornejo-Mazzuchelli A; Hernández-Barrera V; Pellicer-Valero OJ
JAMA Netw Open; 2022 Nov; 5(11):e2242106. PubMed ID: 36378309
[TBL] [Abstract][Full Text] [Related]
4. Post-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patients.
Román-Montes CM; Flores-Soto Y; Guaracha-Basañez GA; Tamez-Torres KM; Sifuentes-Osornio J; González-Lara MF; de León AP
Front Public Health; 2023; 11():1155951. PubMed ID: 37255755
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal course and predictors of health-related quality of life, mental health, and fatigue, in non-hospitalized individuals with or without post COVID-19 syndrome.
Kirchberger I; Meisinger C; Warm TD; Hyhlik-Dürr A; Linseisen J; Goßlau Y
Health Qual Life Outcomes; 2024 Apr; 22(1):32. PubMed ID: 38616282
[TBL] [Abstract][Full Text] [Related]
6. Fatigue and Dyspnoea as Main Persistent Post-COVID-19 Symptoms in Previously Hospitalized Patients: Related Functional Limitations and Disability.
Fernández-de-Las-Peñas C; Palacios-Ceña D; Gómez-Mayordomo V; Palacios-Ceña M; Rodríguez-Jiménez J; de-la-Llave-Rincón AI; Velasco-Arribas M; Fuensalida-Novo S; Ambite-Quesada S; Guijarro C; Cuadrado ML; Florencio LL; Arias-Navalón JA; Ortega-Santiago R; Elvira-Martínez CM; Molina-Trigueros LJ; Torres-Macho J; Sebastián-Viana T; Canto-Diez MG; Cigarán-Méndez M; Hernández-Barrera V; Arendt-Nielsen L
Respiration; 2022; 101(2):132-141. PubMed ID: 34569550
[TBL] [Abstract][Full Text] [Related]
7. Persistent effects of COVID-19 in patients hospitalized during the first wave of the pandemic: The impact of persistent fatigue on quality of life in a cross-sectional study.
Skinner JP; Moran LV
J Med Virol; 2023 Feb; 95(2):e28491. PubMed ID: 36832543
[TBL] [Abstract][Full Text] [Related]
8. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study.
Menges D; Ballouz T; Anagnostopoulos A; Aschmann HE; Domenghino A; Fehr JS; Puhan MA
PLoS One; 2021; 16(7):e0254523. PubMed ID: 34252157
[TBL] [Abstract][Full Text] [Related]
9. Determinants of post-acute COVID-19 syndrome among hospitalized severe COVID-19 patients: A 2-year follow-up study.
Elias TP; Gebreamlak TW; Gebremeskel TT; Adde BL; Abie AS; Elias BP; Argaw AM; Tenaw AA; Belay BM
PLoS One; 2024; 19(5):e0298409. PubMed ID: 38728331
[TBL] [Abstract][Full Text] [Related]
10. Long-term health consequences of COVID-19 in survivors hospitalised at a tertiary care hospital and their correlation with acute COVID-19 severity and associated risk factors.
Jain V; Nabi N; Aggarwal S; Alam Z; Chandra K; Singh D; Kashyap V; Islam F; Kohli S
J Clin Nurs; 2024 Jan; 33(1):115-125. PubMed ID: 36802108
[TBL] [Abstract][Full Text] [Related]
11. Persistent symptoms, quality of life, and risk factors in long COVID: a cross-sectional study of hospitalized patients in Brazil.
de Oliveira JF; de Ávila RE; de Oliveira NR; da Cunha Severino Sampaio N; Botelho M; Gonçalves FA; Neto CJF; de Almeida Milagres AC; Gomes TCC; Pereira TL; de Souza RP; Molina I
Int J Infect Dis; 2022 Sep; 122():1044-1051. PubMed ID: 35908724
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
[TBL] [Abstract][Full Text] [Related]
14. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis.
Malik P; Patel K; Pinto C; Jaiswal R; Tirupathi R; Pillai S; Patel U
J Med Virol; 2022 Jan; 94(1):253-262. PubMed ID: 34463956
[TBL] [Abstract][Full Text] [Related]
15. Emotional, mental health and physical symptom experience of patients hospitalized with COVID-19 up to 3 months post-hospitalization: A longitudinal study.
Tracy MF; Hagstrom S; Mathiason M; Wente S; Lindquist R
J Clin Nurs; 2024 Feb; 33(2):591-605. PubMed ID: 37698148
[TBL] [Abstract][Full Text] [Related]
16. Severe Post-COVID-19 Condition after Mild Infection: Physical and Mental Health Eight Months Post Infection: A Cross-Sectional Study.
Egger M; Vogelgesang L; Reitelbach J; Bergmann J; Müller F; Jahn K
Int J Environ Res Public Health; 2023 Dec; 21(1):. PubMed ID: 38248486
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with limited functional status among out-of-hospital patients 30 days and one year after a diagnosis of COVID-19: a cohort study.
Laskovski L; Felcar JM; Fillis MMA; Trelha CS
Sci Rep; 2023 Mar; 13(1):3584. PubMed ID: 36869060
[TBL] [Abstract][Full Text] [Related]
18. Sex differences of post-Covid patients undergoing outpatient pulmonary rehabilitation.
Kautzky A; Nopp S; Gattinger D; Petrovic M; Antlinger M; Schomacker D; Kautzky-Willer A; Zwick RH
Biol Sex Differ; 2024 Apr; 15(1):36. PubMed ID: 38650012
[TBL] [Abstract][Full Text] [Related]
19. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
20. Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional observational study.
Walker S; Goodfellow H; Pookarnjanamorakot P; Murray E; Bindman J; Blandford A; Bradbury K; Cooper B; Hamilton FL; Hurst JR; Hylton H; Linke S; Pfeffer P; Ricketts W; Robson C; Stevenson FA; Sunkersing D; Wang J; Gomes M; Henley W; Collaboration LWCR
BMJ Open; 2023 Jun; 13(6):e069217. PubMed ID: 37286327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
